Silo Pharma (SILO) Return on Capital Employed (2017 - 2025)
Historic Return on Capital Employed for Silo Pharma (SILO) over the last 8 years, with Q3 2025 value amounting to 0.91%.
- Silo Pharma's Return on Capital Employed fell 3500.0% to 0.91% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.91%, marking a year-over-year decrease of 3500.0%. This contributed to the annual value of 0.79% for FY2024, which is 3600.0% down from last year.
- As of Q3 2025, Silo Pharma's Return on Capital Employed stood at 0.91%, which was down 3500.0% from 0.99% recorded in Q2 2025.
- In the past 5 years, Silo Pharma's Return on Capital Employed registered a high of 0.24% during Q1 2022, and its lowest value of 0.99% during Q2 2025.
- Moreover, its 5-year median value for Return on Capital Employed was 0.5% (2021), whereas its average is 0.54%.
- In the last 5 years, Silo Pharma's Return on Capital Employed surged by 40200bps in 2021 and then tumbled by -3700bps in 2025.
- Silo Pharma's Return on Capital Employed (Quarter) stood at 0.26% in 2021, then dropped by -16bps to 0.3% in 2022, then crashed by -67bps to 0.51% in 2023, then plummeted by -46bps to 0.74% in 2024, then fell by -23bps to 0.91% in 2025.
- Its Return on Capital Employed stands at 0.91% for Q3 2025, versus 0.99% for Q2 2025 and 0.9% for Q1 2025.